GXMC
TEVA icon

Global X Management Company’s Teva Pharmaceuticals TEVA Stock Holding History

Global X Management Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,171
Closed -$123K – 1197
2018
Q1 		$123K Buy
+7,171
New +$140K ﹤0.01% 955
2017
Q3 		– Sell
-978
Closed -$32K – 1163
2017
Q2 		$32K Buy
978
+132
+16% +$4.09K ﹤0.01% 1028
2017
Q1 		$27K Buy
846
+149
+21% +$5.08K ﹤0.01% 1017
2016
Q4 		$25K Buy
697
+430
+161% +$17.2K ﹤0.01% 965
2016
Q3 		$12K Sell
267
-214
-44% -$11.2K ﹤0.01% 995
2016
Q2 		$24K Buy
481
+81
+20% +$4.31K ﹤0.01% 865
2016
Q1 		$21K Sell
400
-25
-6% -$1.47K ﹤0.01% 786
2015
Q4 		$28K Buy
425
+42
+11% +$2.6K ﹤0.01% 446
2015
Q3 		$22K Sell
383
-117
-23% -$7.59K ﹤0.01% 477
2015
Q2 		$30K Sell
500
-296
-37% -$18.3K ﹤0.01% 450
2015
Q1 		$50K Hold
796
– – ﹤0.01% 363
2014
Q4 		$46K Sell
796
-119
-13% -$6.63K ﹤0.01% 376
2014
Q3 		$49K Buy
915
+309
+51% +$16.4K ﹤0.01% 364
2014
Q2 		$32K Hold
606
– – ﹤0.01% 383
2014
Q1 		$32K Buy
+606
New +$28K ﹤0.01% 367

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Global X Management Company's TEVA Position: Q2 2018 in Review

Global X Management Company sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 7,171 shares — an estimated $123K sold.

Global X Management Company first reported a position in TEVA in Q1 2014 and held it in 15 quarters. The position peaked at $123K in Q1 2018. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • Global X Management Company reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Global X Management Company sold 7,171 Teva Pharmaceuticals shares in Q2 2018, an estimated $123K.
  • Global X Management Company first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Global X Management Company's Teva Pharmaceuticals position peaked at $123K in Q1 2018.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.